Inhibitors of dihydrofolic acid reductase in the therapy of infectious diseases.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004539:Eimeria / Q000187:drug effects; D057487:Enzyme Therapy; D004926:Escherichia coli / Q000201:enzymology; D006168:Guinea Pigs; D007778:Lactobacillus / Q000187:drug effects; D051379:Mice; D010961:Plasmodium / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011739:Pyrimethamine / Q000633:toxicity; D011743:Pyrimidines / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy; D013411:Sulfadiazine / Q000627:therapeutic use; D013762:Tetrahydrofolate Dehydrogenase
D011743:Pyrimidines; D013411:Sulfadiazine; D013762:Tetrahydrofolate Dehydrogenase; D011739:Pyrimethamine